JP2025500123A - ギャップ結合モジュレーターおよび加齢黄斑変性の処置のためのその使用 - Google Patents
ギャップ結合モジュレーターおよび加齢黄斑変性の処置のためのその使用 Download PDFInfo
- Publication number
- JP2025500123A JP2025500123A JP2024529338A JP2024529338A JP2025500123A JP 2025500123 A JP2025500123 A JP 2025500123A JP 2024529338 A JP2024529338 A JP 2024529338A JP 2024529338 A JP2024529338 A JP 2024529338A JP 2025500123 A JP2025500123 A JP 2025500123A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- treatment
- amd
- prevention according
- retinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163292783P | 2021-12-22 | 2021-12-22 | |
| US63/292,783 | 2021-12-22 | ||
| PCT/EP2022/087342 WO2023118366A1 (en) | 2021-12-22 | 2022-12-21 | Gap junction modulators and their use for the treatment of age-related macular degeneration |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025500123A true JP2025500123A (ja) | 2025-01-09 |
| JP2025500123A5 JP2025500123A5 (https=) | 2025-12-25 |
| JPWO2023118366A5 JPWO2023118366A5 (https=) | 2025-12-25 |
Family
ID=84981302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024529338A Pending JP2025500123A (ja) | 2021-12-22 | 2022-12-21 | ギャップ結合モジュレーターおよび加齢黄斑変性の処置のためのその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250018002A1 (https=) |
| EP (1) | EP4452260B1 (https=) |
| JP (1) | JP2025500123A (https=) |
| CN (1) | CN118450892A (https=) |
| CA (1) | CA3240515A1 (https=) |
| DK (1) | DK4452260T3 (https=) |
| FI (1) | FI4452260T3 (https=) |
| IL (1) | IL313729A (https=) |
| WO (1) | WO2023118366A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202310195D0 (en) * | 2023-07-03 | 2023-08-16 | Hastings Nataly | Method for mitigating symptoms of neurological condition and a system therefor |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6259296A (ja) | 1985-09-10 | 1987-03-14 | Green Cross Corp:The | ペプタイド誘導体 |
| IL157447A0 (en) | 2001-02-22 | 2004-03-28 | Zealand Pharma As Zealand Phar | New medical uses of intercellular communication facilitating compounds |
| UA96283C2 (uk) | 2005-12-23 | 2011-10-25 | Зіланд Фарма А/С | Модифіковані міметики лізину |
| PL2468724T3 (pl) | 2006-12-21 | 2016-05-31 | Zealand Pharma As | Synteza związków pirolidynowych |
| JP6989864B2 (ja) * | 2017-05-05 | 2022-02-03 | ジーランド ファーマ，アー／エス | ギャップ結合細胞間コミュニケーションモジュレータ及び糖尿病性眼疾患の治療のためのそれらの使用 |
-
2022
- 2022-12-21 CN CN202280084727.5A patent/CN118450892A/zh active Pending
- 2022-12-21 IL IL313729A patent/IL313729A/en unknown
- 2022-12-21 US US18/708,367 patent/US20250018002A1/en active Pending
- 2022-12-21 CA CA3240515A patent/CA3240515A1/en active Pending
- 2022-12-21 WO PCT/EP2022/087342 patent/WO2023118366A1/en not_active Ceased
- 2022-12-21 DK DK22843707.5T patent/DK4452260T3/da active
- 2022-12-21 FI FIEP22843707.5T patent/FI4452260T3/fi active
- 2022-12-21 EP EP22843707.5A patent/EP4452260B1/en active Active
- 2022-12-21 JP JP2024529338A patent/JP2025500123A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023118366A1 (en) | 2023-06-29 |
| CA3240515A1 (en) | 2023-06-29 |
| US20250018002A1 (en) | 2025-01-16 |
| EP4452260B1 (en) | 2026-01-28 |
| EP4452260A1 (en) | 2024-10-30 |
| IL313729A (en) | 2024-08-01 |
| FI4452260T3 (fi) | 2026-03-30 |
| CN118450892A (zh) | 2024-08-06 |
| DK4452260T3 (da) | 2026-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Baudouin et al. | In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society thesis) | |
| Li et al. | A small molecule inhibitor of VE-PTP activates Tie2 in Schlemm's canal increasing outflow facility and reducing intraocular pressure | |
| US20140357570A1 (en) | Compositions comprising necrosis inhibitors, such as necrostatins, alone or in combination, for promoting axon regeneration and nerve function, thereby treating cns disorders | |
| Iwase et al. | Topical pazopanib blocks VEGF-induced vascular leakage and neovascularization in the mouse retina but is ineffective in the rabbit | |
| Wang et al. | The antiangiogenic effects of integrin α5β1 inhibitor (ATN-161) in vitro and in vivo | |
| JP2023553414A (ja) | ドライ型加齢黄斑変性症（ａｍｄ）治療用組成物 | |
| JP2023166585A (ja) | サイトカインモジュレーション | |
| US20220133866A1 (en) | Method for the Treatment of a Disease Using Pigment Epithelium-Derived Factor (PEDF) | |
| JP2025500123A (ja) | ギャップ結合モジュレーターおよび加齢黄斑変性の処置のためのその使用 | |
| Daftarian et al. | Intravitreal connective tissue growth factor neutralizing antibody or bevacizumab alone or in combination for prevention of proliferative vitreoretinopathy in an experimental model | |
| JP6989864B2 (ja) | ギャップ結合細胞間コミュニケーションモジュレータ及び糖尿病性眼疾患の治療のためのそれらの使用 | |
| US20230338483A1 (en) | Method for the treatment of a disease using pigment epithelium-derived factor (pedf) | |
| EA051681B1 (ru) | Модуляторы щелевых контактов и их применение для лечения возрастной макулярной дегенерации | |
| Evereklioglu et al. | Aqueous humor adrenomedullin levels differ in patients with different types of glaucoma | |
| KR102023827B1 (ko) | 안구 건조증 질환의 치료 및/또는 예방을 위한 짧은 합성 펩티드의 용도 | |
| US20170027936A1 (en) | Abl1 inhibitor for treating and preventing ocular neovascularisation | |
| US20220280473A1 (en) | Compositions and methods for modulating epithelial-mesenchymal transition | |
| TW202532435A (zh) | 治療新生血管性眼疾之方法 | |
| JP2022529505A (ja) | 上皮および関門の完全性を保護するための組成物および方法 | |
| US10973867B2 (en) | Compositions and methods for treating retinopathy | |
| CA3075146A1 (en) | Methods and uses of compounds for treatment of choriocapillaris disorders | |
| Riu et al. | Serine/arginine rich protein kinase-1 (SRPK1) inhibition for the treatment of diabetic 1 retinopathy 2 3 Naseeb K Malhi1, Claire L Allen1, Elizabeth Stewart2, Katherine L Horton1, Federica 4 | |
| Cheng et al. | Regulation of gap junction coupling in bovine ciliary | |
| HK40000030B (en) | Compositions and methods for treating retinopathy | |
| BRPI0617297A2 (pt) | composiÇÕes e mÉtodos para tratamento de hipersecreÇço das vias aÉreas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251217 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20251217 |